Multivariate analysis of human immunodeficiency virus type 1 neutralization data

Journal of Virology

Volumn 70, Issue 9, 1996, Pages 6235-6243

  Nyambi, Phillipe N ^a   Nkengasong, John ^a   Lewi, Paul ^b   Andries, Koen ^b   Janssens, Wouter ^a   Fransen, Katrien ^a   Heyndrickx, Leo ^a   Piot, Peter ^a   Van Der Groen, Guido ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; EPITOPE MAPPING; GENETIC ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION; VIRUS GENE; VIRUS NEUTRALIZATION;

EID: 0029839390     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.9.6235-6243.1996     Document Type: Article

References (37)

1. Abimiku, A. G., T. L. Stern, A. Zwandor, P. D. Markham, C. Calef. S. Kyari, W. C. Saxinger, R. C. Gallo, M. Robert-Guroff, and M. S. Reitz. 1994. Subgroup G HIV type 1 isolates from Nigeria. AIDS Res. Hum. Retroviruses 10:1581-1583.
2. Allen, D. M. 1974. The relationship between variable selection and data argumentation and a method for prediction, Technometrics 16:125-127.
3. Andries, K., B. Dewindt, J. Snoeks, L. Wouters, H. Moereels, P. J. Lewi, and P. A. J. Janssen. 1990. Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J. Virol. 64:1117-1123.
4. Baskar, P. V., S. C. Ray, R. Rao, T. C. Quinn, J. E. K. Hildreth, and R. C. Bollinger. 1994. Presence in India of HIV type 1 similar to North American strains. AIDS Res. Hum. Retroviruses 10:1039-1041.
5. Bobkov, A., R. Cheingsong-Popov, M. Garaev, A. Rzhaninova, P. Kallebu, S. Beddows, M. H. Bachmann, J. I. Mullins, J. Louwagie, W. Janssens, G. van der Groen, F. McCutchan, and J. Weber. 1994. Identification of an enr G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus. AIDS 8:1649-1655.
6. Broliden, P. A., A. Von Gegerfelt, P. Clapham, et al. 1992. Identification of human neutralizing-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Immunology 89:461-465.
7. Bruce, C., C. Clegg, A. Featherstone, J. Smith, B. Biryahawaho, R. Downing, and J. Oram. 1994. Presence of multiple genetic subtypes of human immunodeficiency virus type-1 proviruses in Uganda. AIDS Res. Hum. Retroviruses 10:1543-1550.
8. Dumitrescu, O., M. L. Kalish, S. C. Kliks, C. I. Bandea, and J. A. Levy. 1994. Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype. J. Infect. Dis. 169:281-288.
9. Earl, P. L., C. C. Broder, D. Long, S. A. Lee, J. Peterson, S. Chakrabarti, R. W. Doms, and B. Moss. 1994. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J. Virol. 68:3015-3026.
10. Gao, F., L. Yue, S. Craig, C. L. Thortnon, D. L. Robertson, F. E. McCutchan, J. A. Bradac, P. M. Sharp, B. H. Hahn, and the WHO Network for HIV Isolation and Characterization. 1994. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C and E. AIDS Res. Hum. Retroviruses 10:1359-1368.
11. Goudsmit, J., C. L. Kuiken, and P. L. Nara. 1989. Linear versus confirmational variation of V3 neutralization domains of HIV-1 during experimental and natural infection. AIDS 3(Suppl. 3):S119-S123.
12. Ho, D. D., J. A. McKeating, X. L. Li, T. Moudgil, E. S. Daar, N.-C. Sun, and J. Robinson. 1991. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J. Virol. 65:489-493.
13. Janssens, W., L. Heyndrickx, K. Fransen, J. Motte, M. Peeters, J. N. Nkengasong, P. M. Ndumbe, E. Delaporte, J.-L. Perret, C. Atende, P. Piot, and G. van der Groen. 1994. Genetic and phylogenetic analysis of env subtypes G and H in Central Africa. AIDS Res. Hum. Retroviruses 10:877-879.
14. Janssens, W., L. Heyndrickx, Y. Van de Peer, A. Bouckaert, K. Fransen, J. Motte, G.-M. Gersby-Damet, M. Peeters, P. Piot, and G. van der Groen. 1994. Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire. AIDS 8:21-26.
15. Kostrikis, L. G., E. Bagdades, Y. Cao, L. Zhang, D. Dimitriou, and D. D. Ho. 1995. Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus; identification of a new subtype designated subtype I. J. Virol. 69:6122-6130.
16. Kostrikis, L. G., Y. Cao, H. Ngai, J. P. Moore, and D. D. Ho. 1996. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J. Virol. 70:445-458.
17. Lewi, P. J. 1976. Spectral mapping, a technique for classifying biological activity profiles of chemical compounds. Drug Res. 26:1295.
18. Lewi, P. J. 1982. Multivariate data analysis in industrial practice. Research Studies Press, Wiley, Chichester, England.
19. Lewi, P. J. 1989. Spectral map analysis. Analysis of contrasts especially from log ratios. Chemometrics Intelligent Lab. Syst. 5:105-116.
20. Lewi, P. J. 1995. Spectral mapping of drug-test specificities, p. 219-253. In H. van de Waterbeemd (ed.), Chemometrics in molecular design. VCH, Weinheim, Germany.
21. Louwagie, J., W. Janssens, J. Mascola, L. Heyndrickx, P. Hegerich, G. van der Groen, F. E. McCutchan, and D. S. Burke. 1995. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J. Virol. 69:263-271.
22. Louwagie, J., F. McCutchan, J. Mascola, G. Eddy, K. Fransen, M. Peeters, G. van der Groen, and D. Burke, 1994. Session II. Technical challenges and scientific issues: genetic subtypes of HIV-1. AIDS Res. Hum. Retroviruses 9(Suppl.):S147-S150.
23. Louwagie, J., F. E. McCutchan, M. Peeters, T. P. Brennan, E. Sanders-Buell. G. A. Eddy, G. van der Groen, K. Fransen, G.-M. Gershy-Damet, R. Deleys, and D. S. Burke. 1993. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 7:769-780.
24. Moore, J. P., Y. Cao, J. Leu, L. Qin, B. Korber, and D. D. Ho. 1996. Interand intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J. Virol. 70:427-444.
25. Moore, J. P., and D. D. Ho. 1992. Conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67:863-875.
26. Moore, J. P., M. Thali, B. A. Jameson, et al. 1993. Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop. J. Virol. 67:4785-4796.
27. Morgado, M. G., E. C. Sabino, E. G. Shpaer, V. Bongertz, L. Brigido, M. D. C. Guimaraes, E. A. Castilho, B. Galvāo-Castro, J. I. Mullins. R. M. Hendry, and A. Mayer. 1994. V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/ European prototype and detection of subtype F. AIDS Res. Hum. Retroviruses 10:569-576.
28. Nkengasong, J. N., W. Janssens, L. Heyndrikx, K. Fransen, P. M. Ndumbe, J. Motte, A, Leonaers, M. Ngolle, J. Ayuk, P. Piot, and G. van der Groen. 1994. Genotypic subtypes of HIV-1 in Cameroon. AIDS 8:1405-1412.
29. IIIB in sera of African and Belgian HIV-1 infected individuals. AIDS 8:1089-1096.
30. Nyambi, P. N., J. Nkengasong, M. Peeters, F. Simon, J. Eberle, W. Janssens, K. Fransen, B. Willems, K. Vereecken, L. Heyndrickx, P. Plot, and G. van der Groen. 1995. Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses. J. Infect. Dis. 172:1228-1237.
31. Profy, A. T., P. A. Salina, L. I. Eckler, N. M. Dunlop, P. L. Nara, and S. D. Putney. 1990. Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual. J. Immunol. 144:4641-4647.
32. Sneath, P. H., and R. R. Sokal. 1973. Numerical taxonomy. Freeman, San Francisco.
33. Stamatatos, L., and C. Cheng-Meyer. 1995. Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding. J. Virol J. 69: 6191-6198.
34. Vanden Haesevelde, M., J.-L. Decourt, R. J. De Leys, B. Vanderborght, G. van der Groen, H. van Heuverswijn, and E. Saman. 1994. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J. Virol. 68:1586-1596.
35. Weiss, R. A., P. R. Clapham, J. N. Weber, A. G. Dalgleish, L. A. Lasky. and P. W. Berman. 1986. Variable and conserved neutralisation antigens of HIV. Nature (London) 324:572-575.
36. Wold, S., C. Albano, W. J. Dunn III, K. Esbensen, S. Hellberg, E. Johansson, and M. Sjostrom. 1983. Pattern recognition: finding and using patterns in multivariate data, p. 147. In H. Martens and H. Russwurm, Jr. (ed.), Food research and data analysis. Applied Science, London.
37. World Health Organization. WHO case definitions for AIDS surveillance in adults and adolescents. 1994. Wkly. Epidemiol. Rec. 69:273-275.